| Literature DB >> 32894171 |
Song-Bo Dong1, Jian-Xian Xiong2, Kai Zhang1, Jun Zheng1, Shang-Dong Xu1, Yong-Min Liu1, Li-Zhong Sun1, Xu-Dong Pan3.
Abstract
BACKGROUND: The optimal hypothermic level in total arch replacement with stented elephant trunk implantation for acute type A aortic dissection (aTAAD) has not been established, and the superiority of unilateral or bilateral cerebral perfusion remains a controversial issue. Therefore, we evaluated the application of moderate hypothermic circulatory arrest (MHCA) with a core temperature of 29 °C and bilateral selective antegrade cerebral perfusion in aTAAD treated by total arch replacement with stented elephant trunk implantation.Entities:
Keywords: Acute type a aortic dissection; Bilateral selective antegrade cerebral perfusion; Moderate hypothermic circulatory arrest; Total arch replacement
Mesh:
Year: 2020 PMID: 32894171 PMCID: PMC7487476 DOI: 10.1186/s13019-020-01284-y
Source DB: PubMed Journal: J Cardiothorac Surg ISSN: 1749-8090 Impact factor: 1.637
Preoperative clinical profiles
| Variable | Control group ( | Modified group ( | |
|---|---|---|---|
| Age, years | 49.8 ± 11 | 50.6 ± 12 | 0.807 |
| Male | 30 (83.3%) | 20 (80%) | 0.739 |
| Hypertension | 30 (83.3%) | 19 (76%) | 0.479 |
| Smoking | 16 (44.4%) | 10 (40%) | 0.730 |
| Malperfusion | 11 (30.6%) | 5 (20%) | 0.357 |
| Pericardial effusion | 20 (55.6%) | 9 (36%) | 0.133 |
| Cardiac tamponade | 1 (2.8%) | 5 (20%) | 0.038 |
| Diabetes mellitus | 1 (2.8%) | 1 (4.0%) | 1.000 |
| Marfan syndrome | 1 (2.8%) | 1 (4.0%) | 1.000 |
| Myocardial infarction history | 2 (5.6%) | 1 (4.0%) | 1.000 |
| Previous cerebrovascular history | 1 (2.8%) | 2 (8.0%) | 0.562 |
| Previous aortic valve replacement | 0 | 1 (4.0%) | 0.410 |
| Previous TEVAR for type B aortic dissection | 0 | 2 (8.0%) | 0.164 |
| Dialysis | 0 | 1 (4.0%) | 0.410 |
| Aortic Regurgitation (moderate or severe) | 12 (33.3%) | 6 (24%) | 0.432 |
| Ejection fraction | 62.1 ± 5.3 | 60.7 ± 6.1 | 0.335 |
Data presented as mean ± SD, or percentages as appropriate
Operative outcomes
| Variable | Control group ( | Modified group ( | |
|---|---|---|---|
| Operation time, h | 7.8 ± 1.2 | 7 ± 0.8 | 0.005 |
| CPB time, min | 218 ± 39 | 174 ± 29.1 | < 0.001 |
| Cross-clamp time, min | 129.3 ± 26.4 | 96.2 ± 20.4 | < 0.001 |
| Lower body circulatory arrest time, min | 22.8 ± 4.9 | 16 ± 4 | < 0.001 |
| Core temperature, °C | 24.6 ± 0.9 | 29 ± 0.8 | < 0.001 |
| Pump pressure, mmHg | 63 ± 14.2 | 65.4 ± 9.8 | 0.430 |
| Cerebral perfusion flow ml/min | 579.4 ± 166 | 571 ± 104.3 | 0.831 |
| ml/kg·min | 7.4 ± 2.0 | 7.8 ± 1.2 | 0.245 |
| uSACP time, min | 40 ± 7.7 | ||
| bSACP time, min | 16 ± 4 | ||
| Aortic sinus repair | 11 (30.6%) | 9 (36%) | 0.656 |
| Ascending aorta replacement | 25 (69.4%) | 17 (68%) | 0.905 |
| Bentall | 11 (30.6%) | 8 (32%) | 0.905 |
| Extra-anatomic bypass | 2 (5.6%) | 0 | 0.508 |
| CABG※ | 2 (5.6%) | 1 (4.0%) | 1.000 |
Data presented as mean ± SD, or percentages as appropriate
※CABG: coronary artery bypass grafting
Postoperative results
| Variable | Control group ( | Modified group ( | |
|---|---|---|---|
| MAEs※ | 11 (30.6%) | 1 (4.0%) | 0.019 |
| In-hospital mortality | 3 (8.3%) | 0 | 0.262 |
| PND | 3 (8.3%) | 0 | 0.262 |
| TND | 5 (13.9%) | 2 (8.0%) | 0.689 |
| New renal failure with CRRT | 5 (13.9%) | 0 | 0.072 |
| Paraplegia | 2 (5.6%) | 1 (4.0%) | 1.000 |
| Re-exploration for bleeding | 2 (5.6%) | 0 | 0.508 |
| Tracheotomy | 2 (5.6%) | 1 (4.0%) | 1.000 |
| Ventilation time, h | 29.8 (13.8, 66.4) | 16 (12, 25) | 0.038 |
| ICU stay time, h | 58.8 (21.6, 148.4) | 34 (18.5, 50) | 0.046 |
| Chest tube drainage, ml/48 h | 1020.6 ± 374 | 797.2 ± 180.1 | 0.004 |
| RBC transfusion, unit※ | 5.5 (0.5, 10) | 2 (0, 6.5) | 0.045 |
| without RBC transfusion | 9 (25%) | 12 (48%) | 0.063 |
Data presented as mean ± SD, range interquartile or percentages as appropriate
※ MAEs: in-hospital mortality, PND, paraplegia, and new renal failure needing CRRT;
RBC red blood cell